152 related articles for article (PubMed ID: 3878524)
1. Stimulant and anxiogenic effects of corticotropin releasing factor.
Koob GF; Thatcher-Britton K
Prog Clin Biol Res; 1985; 192():499-506. PubMed ID: 3878524
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing factor and behavior.
Koob GF; Bloom FE
Fed Proc; 1985 Jan; 44(1 Pt 2):259-63. PubMed ID: 3871412
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat.
Kalivas PW; Duffy P; Latimer LG
J Pharmacol Exp Ther; 1987 Sep; 242(3):757-63. PubMed ID: 3498816
[TBL] [Abstract][Full Text] [Related]
4. Effects of alpha-flupenthixol and naloxone on CRF-induced locomotor activation.
Koob GF; Swerdlow N; Seeligson M; Eaves M; Sutton R; Rivier J; Vale W
Neuroendocrinology; 1984 Nov; 39(5):459-64. PubMed ID: 6096752
[TBL] [Abstract][Full Text] [Related]
5. Effects of urocortin 2 and 3 on motor activity and food intake in rats.
Ohata H; Shibasaki T
Peptides; 2004 Oct; 25(10):1703-9. PubMed ID: 15476937
[TBL] [Abstract][Full Text] [Related]
6. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
Spina MG; Merlo-Pich E; Akwa Y; Balducci C; Basso AM; Zorrilla EP; Britton KT; Rivier J; Vale WW; Koob GF
Psychopharmacology (Berl); 2002 Mar; 160(2):113-21. PubMed ID: 11875628
[TBL] [Abstract][Full Text] [Related]
7. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
Lu L; Liu D; Ceng X; Ma L
Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
[TBL] [Abstract][Full Text] [Related]
8. The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats.
McElroy JF; Ward KA; Zeller KL; Jones KW; Gilligan PJ; He L; Lelas S
Psychopharmacology (Berl); 2002 Dec; 165(1):86-92. PubMed ID: 12474122
[TBL] [Abstract][Full Text] [Related]
9. Altered responsivity to central administrations of corticotropin-releasing factor in rats with a history of opiate exposures.
Blatchford KE; Choi EA; McNally GP
Behav Neurosci; 2006 Oct; 120(5):1169-74. PubMed ID: 17014268
[TBL] [Abstract][Full Text] [Related]
10. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function.
Martínez V; Rivier J; Wang L; Taché Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):754-60. PubMed ID: 9023288
[TBL] [Abstract][Full Text] [Related]
11. Corticotropin releasing factor enhances attentional function as assessed by the five-choice serial reaction time task in rats.
Ohmura Y; Yamaguchi T; Futami Y; Togashi H; Izumi T; Matsumoto M; Yoshida T; Yoshioka M
Behav Brain Res; 2009 Mar; 198(2):429-33. PubMed ID: 19084036
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing factor has an anxiogenic action in the social interaction test.
Dunn AJ; File SE
Horm Behav; 1987 Jun; 21(2):193-202. PubMed ID: 2886414
[TBL] [Abstract][Full Text] [Related]
13. Behavioral effects of central administration of the novel CRF antagonist astressin in rats.
Spina MG; Basso AM; Zorrilla EP; Heyser CJ; Rivier J; Vale W; Merlo-Pich E; Koob GF
Neuropsychopharmacology; 2000 Mar; 22(3):230-9. PubMed ID: 10693150
[TBL] [Abstract][Full Text] [Related]
14. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
Izzo E; Sanna PP; Koob GF
Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
[TBL] [Abstract][Full Text] [Related]
15. A study of the lasting effects of cocaine pre-exposure on anxiety-like behaviors under baseline conditions and in response to central injections of corticotropin-releasing factor.
Erb S; Kayyali H; Romero K
Pharmacol Biochem Behav; 2006 Sep; 85(1):206-13. PubMed ID: 16987545
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
Menzaghi F; Howard RL; Heinrichs SC; Vale W; Rivier J; Koob GF
J Pharmacol Exp Ther; 1994 May; 269(2):564-72. PubMed ID: 8182523
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of LH release by CRF may be partially mediated through hypothalamic beta-endorphin release.
Nikolarakis KE; Almeida OF; Herz A
NIDA Res Monogr; 1986; 75():403-5. PubMed ID: 2963219
[TBL] [Abstract][Full Text] [Related]
18. Differential dose effects of central CRF and effects of CRF astressin on pig behavior.
Salak-Johnson JL; Anderson DL; McGlone JJ
Physiol Behav; 2004 Oct; 83(1):143-50. PubMed ID: 15501501
[TBL] [Abstract][Full Text] [Related]
19. Effects of the traditional Japanese medicine Unkei-to on the corticotropin-releasing factor-induced increase in locomotor activity.
Terawaki K; Koike K; Yuzurihara M; Kase Y; Takeda S; Aburada M; Murakami K; Ohno S; Suzuki N; Inoue M
Pharmacol Biochem Behav; 2004 Aug; 78(4):799-803. PubMed ID: 15301938
[TBL] [Abstract][Full Text] [Related]
20. The behavioural and electrophysiological effects of CRF in rat frontal cortex.
Zieba B; Grzegorzewska M; Brański P; Domin H; Wierońska JM; Hess G; Smiałowska M
Neuropeptides; 2008; 42(5-6):513-23. PubMed ID: 18617263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
